全文获取类型
收费全文 | 17316篇 |
免费 | 873篇 |
国内免费 | 92篇 |
专业分类
耳鼻咽喉 | 177篇 |
儿科学 | 372篇 |
妇产科学 | 358篇 |
基础医学 | 1979篇 |
口腔科学 | 1453篇 |
临床医学 | 1160篇 |
内科学 | 4549篇 |
皮肤病学 | 433篇 |
神经病学 | 1410篇 |
特种医学 | 299篇 |
外科学 | 2514篇 |
综合类 | 90篇 |
一般理论 | 4篇 |
预防医学 | 1239篇 |
眼科学 | 372篇 |
药学 | 757篇 |
中国医学 | 81篇 |
肿瘤学 | 1034篇 |
出版年
2024年 | 11篇 |
2023年 | 131篇 |
2022年 | 275篇 |
2021年 | 584篇 |
2020年 | 332篇 |
2019年 | 530篇 |
2018年 | 616篇 |
2017年 | 408篇 |
2016年 | 423篇 |
2015年 | 523篇 |
2014年 | 739篇 |
2013年 | 898篇 |
2012年 | 1459篇 |
2011年 | 1584篇 |
2010年 | 896篇 |
2009年 | 733篇 |
2008年 | 1201篇 |
2007年 | 1367篇 |
2006年 | 1154篇 |
2005年 | 1015篇 |
2004年 | 895篇 |
2003年 | 742篇 |
2002年 | 757篇 |
2001年 | 88篇 |
2000年 | 60篇 |
1999年 | 72篇 |
1998年 | 113篇 |
1997年 | 96篇 |
1996年 | 82篇 |
1995年 | 53篇 |
1994年 | 55篇 |
1993年 | 44篇 |
1992年 | 25篇 |
1991年 | 22篇 |
1990年 | 23篇 |
1989年 | 11篇 |
1988年 | 16篇 |
1987年 | 12篇 |
1986年 | 11篇 |
1985年 | 12篇 |
1984年 | 26篇 |
1983年 | 19篇 |
1982年 | 11篇 |
1981年 | 24篇 |
1980年 | 20篇 |
1979年 | 10篇 |
1978年 | 8篇 |
1977年 | 18篇 |
1976年 | 13篇 |
1974年 | 6篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
992.
BACKGROUND: We analysed the experience with hypertrophic cardiomyopathy in two paediatric centres to establish the differences from older patients. METHODS: Out of 45 young patients seen from 1974 to 1999, we included 38. Criterions for exclusion were secondary forms, or association with severe congenital cardiac disease which could alter the outcome. RESULTS: The patients presented at the age of 5.7 years, and were followed for 7.0 years. The 34 patients referred because of a murmur or cardiomegaly were older than the four with heart failure, presenting at 6.2 as opposed to 2.1 years of age, p = 0.08. Of the patients, 29 (76%) had primary cardiomyopathy, while 9 (24%) had secondary forms associated with Noonan's and LEOPARD syndromes. Familial tendency was ascertained in 7 patients (18%). The septal thickness in mm/m2 at presentation was greater in patients under 2 years than in older children (29 vs 18, p = 0.02). Obstructive hypertrophic cardiomyopathy was found in 17 patients (45%), with six of these having mild associated congenital cardiac defects. Nine had symptomatic arrhythmias. Overall, treatment was medical in 31, with DDD pacing used in 5, and surgery, radiofrequency ablation, and transplantation in one patient each. Total mortality was 24%, at a rate of 4.3% per year. Four patients died in heart failure and 5 had sudden death. Those in failure were significantly younger (p = 0.01). CONCLUSIONS: Hypertrophic cardiomyopathy in the young is characterized by referral for murmur or heart failure; frequent secondary forms; the obstructive variant being as common as the non-obstructive form; a mortality rate similar to that for adults attending tertiary centres; and less frequent familial forms than in older populations. 相似文献
993.
994.
995.
Bayón Fernández J Alegría Ezquerra E Bosch Genover X Cabadés O'Callaghan A Iglesias Gárriz I Jiménez Nácher JJ Malpartida De Torres F Sanz Romero G;Grupo de Trabajo ad hoc de la Sección de Cardiopatía Isquémica y Unidades Coronarias de la Sociedad Española de Cardiología 《Revista espa?ola de cardiología》2002,55(2):143-154
The two main goals of chest pain units are the early, accurate diagnosis of acute coronary syndromes and the rapid, efficient recognition of low-risk patients who do not need hospital admission. Many clinical, practical, and economic reasons support the establishment of such units. Patients with chest pain account for a substantial proportion of emergency room turnover and their care is still far from optimal: 8% of patients sent home are later diagnosed of acute coronary syndrome and 60% of admissions for chest pain eventually prove to have been unnecessary.We present a systematic approach to create and manage a chest pain unit employing specialists headed by a cardiologist. The unit may be functional or located in a separate area of the emergency room. Initial triage is based on the clinical characteristics, the ECG and biomarkers of myocardial infarct. Risk stratification in the second phase selects patients to be admitted to the chest pain unit for 6-12 h. Finally, we propose treadmill testing before discharge to rule out the presence of acute myocardial ischemia or damage in patients with negative biomarkers and non-diagnostic serial ECGs. 相似文献
996.
López-Palop R Pinar E Lozano I Carrillo P Cortés R Picó F Valdés M 《Revista espa?ola de cardiología》2002,55(3):251-257
INTRODUCTION: Earlier studies have established the value of coronary pressure wires for diagnosing and monitoring the treatment of patients with coronary artery disease. In this study we demonstrated their usefulness in the daily clinical practice of a catheterization laboratory. MATERIAL AND METHODS: A retrospective study of the use of pressure wires in our laboratory between October 1998 and November 2000. The pressure wire was inserted whenever the interventional cardiologist considered it to be indicated. In all cases, pressures were recorded with a Waveguide Cardiometrics 0.014 guide (Endosonics) and hyperemia was induced by intracoronary adenosine. RESULTS: Two hundred fifty-three lesions were studied in 190 patients. Indications were functional evaluation of lesions of intermediate severity for 82% (9% intrastent restenoses); guidance of balloon PTCA for 5%; and fulfillment of a research protocol for 13%. Twenty-six percent of lesions considered to be of moderate severity based on angiography were treated as a consequence of the pressures measured by the wire. A decision to begin or continue a procedure was based on wire pressures in 24% and intervention was avoided in 60%. No major complications attributable to the wire were observed. A lesion was dissected in one patient (0.5%) but it was treated without consequences. Twenty pressure wires (11%) failed to work properly during the procedure, fourteen of them (7%) before insertion. The wire could not be advanced across the lesion in one case. CONCLUSIONS: The pressure wire is useful in the daily clinical practice of a catheterization laboratory. Its most common indication is the evaluation of lesions of intermediate or unknown severity, and use is associated with few complications. 相似文献
997.
Colonic tuberculosis 总被引:1,自引:0,他引:1
Villanueva Sáenz E Martínez Hernández Magro P Fernando Alvarez-Tostado Fernández J Valdés Ovalle M 《Digestive diseases and sciences》2002,47(9):2045-2048
Tubercle bacillus was discovered in 1882 by Robert Koch. With the introduction of chemotherapy for tuberculosis in the 1940s the incidence of this entity decreased. The incidence of the tuberculosis of the colon began to increase at the 1980s with the rise in numbers of patients considered as high risk for this entity, such as HIV-infected individuals, patients with chronic renal disease, and immunosuppressed patients with prolonged steroid therapy. We report on two patients with history of chronic abdominal pain and weight loss with a palpable mass in the right lower quadrant. In one patient chest radiography revealed a miliary reticulonodular pattern. In both, abdominal CT scan showed retroperitoneal lymphadenopathy and colonic wall thickness. Colonoscopic examination showed ulcerative lesions and ileocecal valve disruption. Microscopic examination of intestinal content showed evidenced M. tuberculosis. Tuberculosis of the colon should be suspected in patients suffering from chronic abdominal pain and weight loss. 相似文献
998.
999.
De Gregorio MA Mainar A Tejero E Alfonso E Gimeno MJ Herrera M 《European radiology》2002,12(9):2250-2252
We describe a technical modification of Wallstent implantation for the treatment of malignant rectosigmoid and descending colonic obstructions. The modification is the routine placement of an introducer sheath via the rectum before stent implantation in order to straighten the rectosigmoid region. This device facilitates catheter and guide wire manipulations and obtaining specimen biopsies for histopathological studies. The introducer sheath has been used without complications in 21 consecutive patients. 相似文献
1000.
Mixéu MA Vespa GN Forleo-Neto E Toniolo-Neto J Alves PM 《Aviation, space, and environmental medicine》2002,73(9):876-880
BACKGROUND: Approximately 10% of the general population worldwide acquires influenza infection every year. Airline crews run a particularly high risk of contracting influenza and influenza-like viruses because they come in contact with hundreds of potentially infected individuals every day. Respiratory diseases are the most frequent cause of absenteeism among flight crews in airline companies. Several studies have shown the efficacy of influenza vaccination in the workplace of healthy, working adults leading to increased productivity and lower absenteeism. We conducted a double blind, randomized, placebo-controlled study on flight crews of an airline company in order to determine the safety and efficacy of a trivalent inactivated influenza vaccine in reducing illness and absences from work. METHODS: The 813 healthy members of a Brazilian airline company were randomly assigned to receive injections of either an influenza vaccine or a placebo, with a follow-up period of 7 mo after vaccination. Primary outcomes included influenza-like illness episodes and absenteeism from work due to such episodes. RESULTS: Demographic characteristics were similar in the two groups. No significant side-effects occurred in either group. Compared to the placebo group, individuals receiving the vaccine showed 39.5% fewer episodes of flu-like illness (p < 0.001) and 26% fewer days of work lost (p = 0.03).The vaccinated group developed 33% fewer episodes of any severe flu-like illness (p < 0.01). CONCLUSION: The data indicates that influenza vaccination is safe in airline flight crews and may produce health-related benefits including reduced absenteeism. 相似文献